$ANVI
ANVI GLOBAL HOLDINGS, INC.

2024 Q4 Form 10-Q Financial Statement

#000107997324001391 Filed on October 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $51.01K
YoY Change -2.58%
Operating Profit -$51.01K
YoY Change -2.58%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$51.01K
YoY Change -2.58%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$51.01K
YoY Change -2.58%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 120.0M shares 120.0M shares
Diluted Shares Outstanding 120.0M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.926K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $5.200K
Receivables
Other Receivables
Total Short-Term Assets $8.126K
YoY Change 55.7%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $8.126K
Total Long-Term Assets $0.00
Total Assets $8.126K
YoY Change 55.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.56K
YoY Change -20.8%
Accrued Expenses $900.0K
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.074M
YoY Change 10.81%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.074M
Total Long-Term Liabilities
Total Liabilities $2.074M
YoY Change 10.81%
SHAREHOLDERS EQUITY
Retained Earnings -$2.125M
YoY Change 10.36%
Common Stock $58.50K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.066M
YoY Change
Total Liabilities & Shareholders Equity $8.126K
YoY Change 55.7%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$51.01K
YoY Change -2.58%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Address Address Line1
EntityAddressAddressLine1
1135 Kildaire Farm Road
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2926 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5200 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
8126 usd
CY2024Q3 us-gaap Assets
Assets
8126 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
20562 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
577905 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2074467 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2074467 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
119950 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-61450 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2124841 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-2066341 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8126 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-51012 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001570132
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Period End Date
DocumentPeriodEndDate
2024-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-188648
dei Entity Registrant Name
EntityRegistrantName
ANVI GLOBAL HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1226144
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 319-4
dei Entity Address City Or Town
EntityAddressCityOrTown
Cary
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27511
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
821-4491
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119950000 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1334 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
14334 usd
CY2024Q1 us-gaap Assets
Assets
14334 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21761 usd
CY2024Q3 ANVI Accounts Payable Related Party
AccountsPayableRelatedParty
576000 usd
CY2024Q1 ANVI Accounts Payable Related Party
AccountsPayableRelatedParty
504000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
548805 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1974566 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1974566 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119950000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119950000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119950000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119950000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
119950 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-61450 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2018732 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1960232 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14334 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51012 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52365 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106109 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106043 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
51012 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
52365 usd
us-gaap Operating Expenses
OperatingExpenses
106109 usd
us-gaap Operating Expenses
OperatingExpenses
106043 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-51012 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-52365 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-106109 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-106043 usd
CY2024Q3 ANVI Gain From Settlement Of Accounts Payable
GainFromSettlementOfAccountsPayable
0 usd
CY2023Q3 ANVI Gain From Settlement Of Accounts Payable
GainFromSettlementOfAccountsPayable
0 usd
ANVI Gain From Settlement Of Accounts Payable
GainFromSettlementOfAccountsPayable
0 usd
ANVI Gain From Settlement Of Accounts Payable
GainFromSettlementOfAccountsPayable
14051 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14051 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51012 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52365 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106109 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-91992 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52365 usd
us-gaap Net Income Loss
NetIncomeLoss
-106109 usd
us-gaap Net Income Loss
NetIncomeLoss
-91992 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119950000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119950000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119950000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119950000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119950000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119950000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119950000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119950000 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1960232 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-55097 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-2015329 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-51012 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-2066341 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1774857 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39627 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1814484 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52365 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1866849 usd
us-gaap Net Income Loss
NetIncomeLoss
-106109 usd
us-gaap Net Income Loss
NetIncomeLoss
-91992 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
14051 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7800 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7500 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1199 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8890 usd
ANVI Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
72000 usd
ANVI Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
72000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27508 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35433 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
29100 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
34085 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29100 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34085 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1592 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1348 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1334 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1567 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2926 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zJRfiK4lMAA8" style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_860_z5fdEwlXFLg5">Use of Estimates</span></span></i></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zSXsxXV0oOt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_865_ztJWwMopoycd">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2124841 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5200 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
577905 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
548805 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-001391-index-headers.html Edgar Link pending
0001079973-24-001391-index.html Edgar Link pending
0001079973-24-001391.txt Edgar Link pending
0001079973-24-001391-xbrl.zip Edgar Link pending
anvi-20240831.xsd Edgar Link pending
anvi_10q-083124.htm Edgar Link pending
anvi-20240831_cal.xml Edgar Link unprocessable
anvi-20240831_def.xml Edgar Link unprocessable
anvi-20240831_lab.xml Edgar Link unprocessable
anvi-20240831_pre.xml Edgar Link unprocessable
anvi_10q-083124_htm.xml Edgar Link completed
ex31x1.htm Edgar Link pending
ex32x1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending